SE368397B - - Google Patents
Info
- Publication number
- SE368397B SE368397B SE02671/71A SE267171A SE368397B SE 368397 B SE368397 B SE 368397B SE 02671/71 A SE02671/71 A SE 02671/71A SE 267171 A SE267171 A SE 267171A SE 368397 B SE368397 B SE 368397B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR707007551A FR2081561B1 (xx) | 1970-03-03 | 1970-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE368397B true SE368397B (xx) | 1974-07-01 |
Family
ID=9051572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE02671/71A SE368397B (xx) | 1970-03-03 | 1971-03-02 |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5343497B1 (xx) |
| AT (1) | AT307636B (xx) |
| BE (1) | BE763660A (xx) |
| CA (1) | CA934367A (xx) |
| CH (1) | CH536829A (xx) |
| DE (1) | DE2109853B2 (xx) |
| DK (1) | DK124127B (xx) |
| ES (1) | ES388783A1 (xx) |
| FR (1) | FR2081561B1 (xx) |
| GB (1) | GB1323383A (xx) |
| IL (1) | IL36214A (xx) |
| NL (1) | NL169592C (xx) |
| SE (1) | SE368397B (xx) |
| ZA (1) | ZA711131B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1173408B (it) * | 1984-02-29 | 1987-06-24 | Hudson Italiana Spa | Ventilatore,del tipo a pale cave,avente l'interno di ciascuna pala sotto vuoto |
| DE102007027636A1 (de) * | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1487510A (fr) * | 1965-06-01 | 1967-07-07 | Merck & Co Inc | Procédé de fabrication de gonénols et gonadiénols substitués |
-
1970
- 1970-03-03 FR FR707007551A patent/FR2081561B1/fr not_active Expired
-
1971
- 1971-02-17 IL IL36214A patent/IL36214A/xx unknown
- 1971-02-22 ZA ZA711131A patent/ZA711131B/xx unknown
- 1971-03-02 NL NLAANVRAGE7102735,A patent/NL169592C/xx not_active IP Right Cessation
- 1971-03-02 CA CA106701A patent/CA934367A/en not_active Expired
- 1971-03-02 CH CH302971A patent/CH536829A/fr not_active IP Right Cessation
- 1971-03-02 ES ES388783A patent/ES388783A1/es not_active Expired
- 1971-03-02 DK DK95871AA patent/DK124127B/da not_active IP Right Cessation
- 1971-03-02 SE SE02671/71A patent/SE368397B/xx unknown
- 1971-03-02 BE BE763660A patent/BE763660A/xx not_active IP Right Cessation
- 1971-03-02 AT AT177571A patent/AT307636B/de not_active IP Right Cessation
- 1971-03-02 DE DE2109853A patent/DE2109853B2/de active Granted
- 1971-03-02 JP JP1043271A patent/JPS5343497B1/ja active Pending
- 1971-04-19 GB GB2297071A patent/GB1323383A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL169592C (nl) | 1982-08-02 |
| ZA711131B (en) | 1972-03-29 |
| CA934367A (en) | 1973-09-25 |
| DE2109853B2 (de) | 1979-06-21 |
| JPS5343497B1 (xx) | 1978-11-20 |
| GB1323383A (en) | 1973-07-11 |
| FR2081561A1 (xx) | 1971-12-10 |
| IL36214A (en) | 1974-09-10 |
| IL36214A0 (en) | 1971-04-28 |
| DE2109853A1 (de) | 1971-09-23 |
| DE2109853C3 (xx) | 1980-02-21 |
| CH536829A (fr) | 1973-05-15 |
| FR2081561B1 (xx) | 1973-04-06 |
| DK124127B (da) | 1972-09-18 |
| BE763660A (fr) | 1971-09-02 |
| NL7102735A (xx) | 1971-09-07 |
| ES388783A1 (es) | 1974-02-16 |
| AT307636B (de) | 1973-05-25 |